Vincenzo Panasiti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Vincenzo Panasiti has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Stefano Calvieri
Dermatology Clinic, Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, 00185 Rome, Italy
11 shared publications - Ugo Bottoni
University Magna Graecia
7 shared publications Michela Curzio
Department of Dermatology University of Rome “La Sapienza” Rome Italy
5 shared publicationsV. Devirgiliis
5 shared publicationsValeria Devirgiliis
Department of Dermatology University of Rome “La Sapienza” Rome Italy
5 shared publicationsVincenzo Roberti
Department of Dermatology University of Rome “La Sapienza” Rome Italy
5 shared publications
Latest Publications
- 16 October 2015
- Published by Wiley in International Journal of Dermatology
- Vol. 55 (6) , 653-656
Dermoscopy of verrucous epidermal nevus: large brown circles as a novel feature for diagnosis
Background: The epidermal nevus is a hamartomatous proliferation of the epithelium that can involve keratinocytes, sebaceous glands, the pilosebaceous unit, and eccrine or apocrine glands. It occurs in one in 1000 live births and most commonly presents as the verrucous type. Dermoscopy is a non‐invasive technique commonly used to differentiate between melanocytic and non‐melanocytic lesions.Objectives: This study was performed to analyze dermoscopic aspects of verrucous epidermal nevi, which have not previously been described.Methods: Dermoscopic analyses of eight different verrucous epidermal nevi were conducted. Each lesion was excised, and its diagnosis was histopathologically confirmed.Results: In non‐melanocytic lesions, a new dermoscopic feature of large brown circles was observed. This characteristic is useful in the diagnosis of verrucous epidermal nevi.Conclusions: Large brown circles represent a specific dermoscopic feature for the diagnosis of verrucous epidermal nevus.
- 16 October 2015
- Published by Wiley in International Journal of Dermatology
- Vol. 55 (6) , 653-656
Dermoscopy of verrucous epidermal nevus: large brown circles as a novel feature for diagnosis
Background: The epidermal nevus is a hamartomatous proliferation of the epithelium that can involve keratinocytes, sebaceous glands, the pilosebaceous unit, and eccrine or apocrine glands. It occurs in one in 1000 live births and most commonly presents as the verrucous type. Dermoscopy is a non‐invasive technique commonly used to differentiate between melanocytic and non‐melanocytic lesions.Objectives: This study was performed to analyze dermoscopic aspects of verrucous epidermal nevi, which have not previously been described.Methods: Dermoscopic analyses of eight different verrucous epidermal nevi were conducted. Each lesion was excised, and its diagnosis was histopathologically confirmed.Results: In non‐melanocytic lesions, a new dermoscopic feature of large brown circles was observed. This characteristic is useful in the diagnosis of verrucous epidermal nevi.Conclusions: Large brown circles represent a specific dermoscopic feature for the diagnosis of verrucous epidermal nevus.
- 1 June 2015
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 72 (6) , e143-e145
Use of dermoscopy in the diagnosis of sebaceoma
- 1 June 2015
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 72 (6) , e143-e145
Use of dermoscopy in the diagnosis of sebaceoma
- 14 March 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 29 (5) , 1028-1029
Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib
- 14 March 2014
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 29 (5) , 1028-1029
Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib
- Open Access
- 30 August 2013
- Published by S. Karger AG in Dermatology
- Vol. 227 (1) , 55-61
Metastatic Volume: An Old Oncologic Concept and a New Prognostic Factor for Stage IV Melanoma Patients
Background: The last melanoma staging system of the 2009 American Joint Committee on Cancer takes into account, for stage IV disease, the serum levels of lactate dehydrogenase (LDH) and the site of distant metastases. Objective: Our aim was to compare the significance of metastatic volume, as evaluated at the time of stage IV melanoma diagnosis, with other clinical predictors of prognosis. Methods: We conducted a retrospective multicentric study. To establish which variables were statistically correlated both with death and survival time, contingency tables were evaluated. The overall survival curves were compared using the Kaplan-Meier method. Results: Metastatic volume and number of affected organs were statistically related to death. In detail, patients with a metastatic volume >15 cm3 had a worse prognosis than those with a volume lower than this value (survival probability at 60 months: 6.8 vs. 40.9%, respectively). The Kaplan-Meier method confirmed that survival time was significantly related to the site(s) of metastases, to elevated LDH serum levels and to melanoma stage according to the latest system. Conclusion: Our results suggest that metastatic volume may be considered as a useful prognostic factor for survival among melanoma patients.
- 30 August 2013
- Published by S. Karger AG in Dermatology
- Vol. 227 (1) , 55-61
Open AccessMetastatic Volume: An Old Oncologic Concept and a New Prognostic Factor for Stage IV Melanoma Patients
Background: The last melanoma staging system of the 2009 American Joint Committee on Cancer takes into account, for stage IV disease, the serum levels of lactate dehydrogenase (LDH) and the site of distant metastases. Objective: Our aim was to compare the significance of metastatic volume, as evaluated at the time of stage IV melanoma diagnosis, with other clinical predictors of prognosis. Methods: We conducted a retrospective multicentric study. To establish which variables were statistically correlated both with death and survival time, contingency tables were evaluated. The overall survival curves were compared using the Kaplan-Meier method. Results: Metastatic volume and number of affected organs were statistically related to death. In detail, patients with a metastatic volume >15 cm3 had a worse prognosis than those with a volume lower than this value (survival probability at 60 months: 6.8 vs. 40.9%, respectively). The Kaplan-Meier method confirmed that survival time was significantly related to the site(s) of metastases, to elevated LDH serum levels and to melanoma stage according to the latest system. Conclusion: Our results suggest that metastatic volume may be considered as a useful prognostic factor for survival among melanoma patients.
- 4 April 2013
- Published by Wiley in International Journal of Dermatology
- Vol. 53 (2) , e103-e106
Ectopic hidradenoma papilliferum dermoscopically mimicking a blue nevus: a case report and review of the literature
- 4 April 2013
- Published by Wiley in International Journal of Dermatology
- Vol. 53 (2) , e103-e106
Ectopic hidradenoma papilliferum dermoscopically mimicking a blue nevus: a case report and review of the literature
- 16 May 2012
- Published by Wiley in International Journal of Dermatology
- Vol. 52 (9) , 1158-1159
The “firework” pattern in dermoscopy
- 16 May 2012
- Published by Wiley in International Journal of Dermatology
- Vol. 52 (9) , 1158-1159
The “firework” pattern in dermoscopy
- 1 May 2011
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 64 (5) , 865-872
Correlation between insulin-like growth factor binding protein-3 serum level and melanoma progression
- 1 May 2011
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 64 (5) , 865-872
Correlation between insulin-like growth factor binding protein-3 serum level and melanoma progression
- 1 October 2010
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 36 (10) , 1521-1528
Predictive Factors for False Negative Sentinel Lymph Node in Melanoma Patients
Sentinel lymph node biopsy (SLNB) represents a useful tool for staging melanoma patients. However false-negative SLNB are reported in the literature. The aim of our study is to identify predictive factors for false-negative SLNB in melanoma patients. We conducted a retrospective analysis on 316 melanoma patients who underwent SLNB and were followed up at the Department of Dermatology and Plastic Surgery of University of Rome "Sapienza" from March 1994 to June 2008. In our patients, SLNB was positive in 35 cases (11.07%) whereas it was negative in 281 cases (88.93%); 12/316 patients (3.8%) had positive SLNB and positive therapeutic lymph node dissection (TLND); 23/316 (7.28%) patients had positive SLNB and negative TLND; 266/316 (84.18%) patients had negative SLNB but without subsequent metastases in the SLN site; 15/316 (4.74%) patients had negative SLNB, but with subsequent metastases in the same SLN site (false-negative patients). Among the different prognostic factors, only ulceration was the main predictive factor for false-negative SLNB, according to statistical analysis (p=.0420). Our data confirm that SLNB is a useful technique for staging melanoma patients. However, in patients with negative SLNB, a closer follow-up is recommended when ulceration is present. The authors have indicated no significant interest with commercial supporters.
- 1 October 2010
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 36 (10) , 1521-1528
Predictive Factors for False Negative Sentinel Lymph Node in Melanoma Patients
Sentinel lymph node biopsy (SLNB) represents a useful tool for staging melanoma patients. However false-negative SLNB are reported in the literature. The aim of our study is to identify predictive factors for false-negative SLNB in melanoma patients. We conducted a retrospective analysis on 316 melanoma patients who underwent SLNB and were followed up at the Department of Dermatology and Plastic Surgery of University of Rome "Sapienza" from March 1994 to June 2008. In our patients, SLNB was positive in 35 cases (11.07%) whereas it was negative in 281 cases (88.93%); 12/316 patients (3.8%) had positive SLNB and positive therapeutic lymph node dissection (TLND); 23/316 (7.28%) patients had positive SLNB and negative TLND; 266/316 (84.18%) patients had negative SLNB but without subsequent metastases in the SLN site; 15/316 (4.74%) patients had negative SLNB, but with subsequent metastases in the same SLN site (false-negative patients). Among the different prognostic factors, only ulceration was the main predictive factor for false-negative SLNB, according to statistical analysis (p=.0420). Our data confirm that SLNB is a useful technique for staging melanoma patients. However, in patients with negative SLNB, a closer follow-up is recommended when ulceration is present. The authors have indicated no significant interest with commercial supporters.
- 1 October 2009
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 61 (4) , 605-610
The reticular point of view in dermatoscopy
- 1 October 2009
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 61 (4) , 605-610
The reticular point of view in dermatoscopy
- 18 August 2009
- Published by Wiley in International Journal of Dermatology
- Vol. 48 (9) , 1006-1010
Amoxicillin–clavulanic acid‐induced linear immunoglobulin A bullous dermatosis: case report and review of the literature
Background Linear immunoglobulin A bullous dermatosis (LABD) is an autoimmune subepidermal blistering disease, rarely induced by drugs.Methods We describe a case of a 47‐year‐old man who developed a severe blistering eruption after therapy with amoxicillin–clavulanic acid.Results Histopathologic examination and direct immunofluorescence were consistent with a diagnosis of LABD. Therapy with dapsone controlled the disease but, after sun exposure, there was a worsening of the illness.Conclusion To our knowledge, this is the first case of amoxicillin–clavulanic acid‐induced LABD in an adult.
- 18 August 2009
- Published by Wiley in International Journal of Dermatology
- Vol. 48 (9) , 1006-1010
Amoxicillin–clavulanic acid‐induced linear immunoglobulin A bullous dermatosis: case report and review of the literature
Background Linear immunoglobulin A bullous dermatosis (LABD) is an autoimmune subepidermal blistering disease, rarely induced by drugs.Methods We describe a case of a 47‐year‐old man who developed a severe blistering eruption after therapy with amoxicillin–clavulanic acid.Results Histopathologic examination and direct immunofluorescence were consistent with a diagnosis of LABD. Therapy with dapsone controlled the disease but, after sun exposure, there was a worsening of the illness.Conclusion To our knowledge, this is the first case of amoxicillin–clavulanic acid‐induced LABD in an adult.